Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.8 USD | +1.16% | -0.14% | -7.22% |
05-02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
05-01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.22% | 9.32B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- (RGEN) REPLIGEN CORPORATION Expects Fiscal Year 2024 EPS Range $1.42 - $1.49